Production (Stage)
ZYUS Life Sciences Corporation
ZYUS.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.32M | 256.10K | 610.80K | 1.89M | 4.43M |
| Total Receivables | 254.40K | 299.80K | 800.80K | 582.70K | 474.80K |
| Inventory | 437.90K | 1.45M | 1.50M | 1.63M | 1.55M |
| Prepaid Expenses | 322.50K | 571.50K | 341.90K | 510.30K | 656.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.34M | 2.58M | 3.25M | 4.61M | 7.11M |
|
|
|||||
| Total Current Assets | 2.34M | 2.58M | 3.25M | 4.61M | 7.11M |
| Net Property, Plant & Equipment | 7.76M | 8.84M | 9.21M | 9.86M | 10.52M |
| Long-term Investments | -- | 4.35M | 4.29M | 4.34M | 4.45M |
| Goodwill | -- | 4.35M | 4.29M | 4.34M | 4.45M |
| Total Other Intangibles | 0.00 | 9.28M | 9.29M | 9.31M | 9.33M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 105.60K | 112.50K | 111.10K | 112.30K | 115.10K |
| Total Assets | 10.20M | 25.15M | 26.15M | 28.23M | 31.52M |
|
|
|||||
| Total Accounts Payable | 3.12M | 6.77M | 5.88M | 4.61M | 2.60M |
| Total Accrued Expenses | 2.34M | -- | -- | -- | 2.47M |
| Short-term Debt | 56.30K | 316.10K | 255.00K | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.56M | 3.50M | 4.87M | 4.85M | 4.96M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 12.08M | 10.58M | 11.01M | 9.46M | 10.03M |
|
|
|||||
| Total Current Liabilities | 12.08M | 10.58M | 11.01M | 9.46M | 10.03M |
| Long-Term Debt | 257.80K | 316.80K | 501.20K | 550.20K | 482.30K |
| Short-term Debt | 56.30K | 316.10K | 255.00K | -- | -- |
| Capital Leases | 1.57M | 1.75M | 1.79M | 1.88M | 1.98M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 1.49M | 1.50M | 1.51M | 1.53M |
| Total Liabilities | 13.91M | 14.13M | 14.80M | 13.40M | 14.02M |
|
|
|||||
| Common Stock & APIC | 115.31M | 120.22M | 116.69M | 117.81M | 120.76M |
| Retained Earnings | -120.93M | -112.70M | -108.38M | -105.99M | -106.15M |
| Treasury Stock & Other | 1.90M | 3.50M | 3.04M | 3.01M | 2.89M |
| Total Common Equity | -3.71M | 11.02M | 11.35M | 14.82M | 17.50M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.71M | 11.02M | 11.35M | 14.82M | 17.50M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.71M | 11.02M | 11.35M | 14.82M | 17.50M |
|
|
|||||